Division/Committee: [BIOT] Division of Biochemical Technology

Succeeding downstream processing, drug product development involves several key areas to support commercialization of products: i. Formulation development: high-throughput screening strategies, formulation impact on modality stability; ii. Development of analytical techniques to evaluate modality quality from processing stresses; iii. Process characterization: freezing & thawing, mixing/dilution, bioburden & sterile filtration, filling techniques, container closures, packaging innovations; iv. Studies focused on simulating clinical stresses: IV bags, material compatibility, light sensitivity, temperature exposure, transportation stress; v. Strategies for accelerating drug product development processes to support accelerated timelines. Please join us in putting the spotlight on this critical part of drug production. We invite presentations relevant to any of these important topics.

Christopher Mensch

Appearances